Medy-Tox (XKRX:086900) Net Change in Cash : ₩12,922 Mil (TTM As of Dec. 2024)

View and export this data going back to 2009. Start your Free Trial

What is Medy-Tox Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Medy-Tox's Net Change in Cash for the three months ended in Dec. 2024 was ₩18,518 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 was ₩12,922 Mil.

Medy-Tox Net Change in Cash Historical Data

The historical data trend for Medy-Tox's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medy-Tox Net Change in Cash Chart

Medy-Tox Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Net Change in Cash

Get a 7-Day Free Trial

23,976.63

27,783.71

-51,089.02

12,558.13

12,922.27

Medy-Tox Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Net Change in Cash	Get a 7-Day Free Trial															-7,037.89	3,371.32	-6,441.98	-2,524.63	18,517.56

Medy-Tox Net Change in Cash Calculation

Medy-Tox's Net Change in Cash for the fiscal year that ended in Dec. 2024 is calculated as

Net Change in Cash	=	Cash Flow from Operations	+	Cash Flow from Investing	+	Cash Flow from Financing	+	Effect of Exchange Rate Changes
	=	36556.164	+	-646.923	+	-24047.92	+	1060.947
	=	12,922

Medy-Tox's Net Change in Cash for the quarter that ended in Dec. 2024

Net Change in Cash = Cash Flow from Operations + Cash Flow from Investing + Cash Flow from Financing + Effect of Exchange Rate Changes

= 15672.57 + 22281.59 + -20755.637 + 1319.04

= 18,518

Net Change in Cash for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩12,922 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medy-Tox Net Change in Cash Related Terms
Thank you for viewing the detailed overview of Medy-Tox's Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Medy-Tox Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medy-Tox Inc (XKRX:086900) » Definitions » Net Change in Cash

Comparable Companies

XKRX:096530 XKRX:950210 XKRX:226950 XKRX:358570 XKRX:347850 XKRX:085660 XKRX:115450 XKRX:005250 XKRX:005690 XKRX:215600 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270

Traded in Other Exchanges

N/A

Address

641-4, Gak-Ri, Ochang-Eup, Cheongwon, KOR, 363885

Website

http://www.medytox.com

Medy-Tox Inc. is a Korea-based company engaged in the development, manufacture, and marketing of biopharmaceuticals. The company's main product is type-A botulium toxin biopharmaceuticals which are used as remedies for blepharospasms, hemifacial spasms, eye wrinkles, hyperhidrosis diseases and infantile cerebral palsy. The group provides its products under the brand names of Neuronox, Siax and others. It distributes its products within Korean and to overseas markets, such as Japan, China, Russia and Europe, among others.

Medy-Tox Headlines

No Headlines